Different behaviors of serum and urinary crosslaps ELISA in the assessment of bone resorption in healthy girls

Clinical Chemistry

Volumn 45, Issue 5, 1999, Pages 682-683

  Traba, Maria Luisa ^a   Calero, Jesús A ^a   Méndez Dávila, Cioly ^a   García Moreno, Carmen ^a   De la Piedra, Concepción ^a  

^a Hospital UniversitarioFundación Jiménez Díaz   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BLOOD LEVEL; BONE METABOLISM; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; NORMAL HUMAN; OSTEOLYSIS; URINE LEVEL;

EID: 0032921476     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/45.5.682     Document Type: Article

References (4)

1. 1. Fledelius C, Johnsen AH, Cloos PAC, Bonde M, Qvist P. Characterization of urinary degradation products derived from type I collagen, J Biol Chem 1997;272:9755-63.
2. 2. Bonde M, Qvist P, Fledelius C, Riis BJ, Christiansen C. Applications of an enzyme immunoassay for a new marker of bone resorption (CrossLaps): follow-up on hormone replacement therapy and osteoporosis risk assessment. J Clin Endocrinol Metab 1995;80:864-8.
3. 3. Rosenquist C, Fledelius C, Christgau S, Pedersen BJ, Bonde M, Qvist P, Christiansen C. Serum CrossLaps One Step ELISA. First application of monoclonal antibodies for measurement in serum of bone-related degradation products from C-terminal telopeptides of type I collagen. Clin Chem 1998;44:2281-9.
4. 4. Christgau S, Rosenquist C, Alexandersen P, Bjarnason NH, Ravn P, Fledelius C, et al. Clinical evaluation of the Serum CrossLaps One Step ELISA, a new assay measuring the serum concentration of bone-derived degradation products of type I collagen C telopeptides, Clin Chem 1998;44:2290-300.